Tag ~biotechnologies

Tag descriptions coming soon to Wherrelz News!


Adaptive and Illumina to make immune sequencing kits for labs streamlining the detection of disease

Tech Moves: Xnorai taps former Auth0 leader as CEO Microsoft adds first CVP of retail and more

Tech Moves: Google snags Georgia Tech AI professor Apptio hires exec from AWS The Riveter names Portland leader and more

Microsoftbacked universal blood test could start diagnosing disease within a small number of years

The voters will see you now: The finalists for Health Innovation of the Year at the GeekWire Awards

Inside the quest for a new COVID19 test: Microsoft Adaptive Biotech and the hidden power of immunity

Adaptive Biotechnologies stock soars 90 after ringing Nasdaq opening bell following 300M IPO

FDA approves Adaptive Biotechs tool to track potential cancer relapses

Auxilium Starts Human Trial for Nerve Implant First Bioprinted in Space

Adaptive plans fall launch of Tcell test for past COVID19 detection as alternative to antibody tests

Adaptive Biotechnologies signs blockbuster deal with Genentech for personalized cancer treatments worth up to 2 billion

Industry slowdown hits Adaptive Biotechs bottom line as COVID immune initiatives show progress

The search for a COVID19 cure: Amgen and Adaptive Biotech partner in quest for new drug

Adaptive Biotechs deal with Amgen influenced by belief that COVID19 may return seasonally like flu

Oisn raises 5M to develop treatments for zombie cells associated with agerelated diseases

Microsoft and Adaptive Biotechnologies partner to study immune response to COVID19

Adaptive Biotechnologies cofounder leaves Fred Hutch IPO filing warned of IP risks from dual roles

GeekWire Awards: Vote for Deal of the Year the top tech acquisition or IPO in the Pacific NW

Alexandria doubles down on decadeslong Seattle biotech bet with Mercer Mega Block deal

Adaptive Biotechnologies and Microsoft team up to track coronavirusfighting cells

Adaptive Biotechnologies set to go public with valuation above 2B in biggest biotech IPO of 2019

Shares of Gatesbacked Vir Bio tumble after 143M IPO to fund infectious disease efforts

Adaptive Biotechnologies will triple size of its Seattle HQ following IPO

Inside the Adaptive Biotech IPO: How two brothers built a big idea into a breakthrough company

Tech Moves: Smartsheet lands its first CMO Eatsa hires former Starbucks digital exec and more

3 leadership lessons from Adaptive Biotechnologies CEO Chad Robins

Tech Moves: GE Healthcare exec joins Microsoft Puppet names new CTO Adaptive Biotech expands

Tech Moves: Amazons director of Alexa Trust BECU adds CIO Lockstep Fabric exit stealth mode

Life sciences startups in Eastern Washington find a welcoming ecosystem away from big cities

Microsoft and Adaptive launch quest for new COVID19 test seek 1k people for immune study

Adaptive Biotechnologies will sell 8M shares to accelerate drug development

IPO filing: Microsoft invested 45M in Adaptive Biotechnologies as part of universal blood test deal

Adaptive Biotechnologies CEO Chad Robins on the power of mom and being a good listener

Andreessen Horowitz backs Synonyms biomanufacturing facilities

Adaptive Biotechnologies shares drop as loss widens in first quarterly earnings since IPO

Seattle techs extraordinary year: These are the stories well remember in the business of innovation

Eye on autism: Inside the quest to develop an objective test for a disorder that impacts millions

Tech Moves: F5 Networks lands former Marketo and JP Morgan execs AI2 adds managing director Groupon snags REI vet and more

How Microsoft and Adaptive Biotech became a single team to build groundbreaking AI diagnostic

Adaptive Biotech revenue rises 65 to 21M loss widens amid big COVID19 immune partnerships

Microsoft partners with Adaptive Biotech on AIdriven blood test to diagnose dozens of diseases at once

Tech Moves: Adaptive Biotech cofounders join life sciences SPAC new edtech execs and more

Adaptive Biotechnologies files for 230M IPO banking on big Microsoft and Genentech deals

Adaptive Biotechnologies posts 263M in Q3 revenue inks partnership with GlaxoSmithKline

Cellink Subsidiary Cytena to Launch World Changing SingleCell Technology

Adaptive Biotech pushes ahead with new Seattle HQ showing strength of life sciences industry

Adaptive Biotechnologies stock soars 85 after ringing Nasdaq opening bell following 300M IPO

Tech Moves: ExJuno CEO Hans Bishop takes over at Grail Amazon Business chief departs Shyft cofounder jumps to Ally and more

Tech Moves: Qualtrics hires Microsoft vet Amazon voice tech leader steps down Future For Us founders start new roles

How these entrepreneurs use phone calls to gain an edge in the digital age